Skip to main content
SpringerLink
Log in

The lack of effect of ziprasidone on platelet serotonin concentration in schizophrenic patients

  • Letter to the Editors
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Daniel DG, Zimbroff DL, Potkin SG, Reeves KR, Harrigan EP, Lakhsminarayanan M, the Ziprasidone Study Group (1999) Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Neuropsychopharmacology 20:491–505

    Article  PubMed  CAS  Google Scholar 

  • Moeller O, Evers S, Deckert J, Baune BT, Dannlowski U, Nguyen DH, Arolt V, Hetzel G (2007) The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features. Prog Neuropsychopharmacol Biol Psychiatry 31:1440–1443

    Article  PubMed  CAS  Google Scholar 

  • Muck-Seler D, Pivac N, Jakovljevic M (1999) Sex differences, season of birth and platelet 5-HT levels in schizophrenic patients. J Neural Transm 106:337–347

    Article  PubMed  CAS  Google Scholar 

  • Muck-Seler D, Pivac N, Sagud M, Jakovljevic M, Mihaljevic-Peles A (2002) The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Prog Neuro-Psychopharmacol Biol Psychiat 26:1235–1243

    Article  CAS  Google Scholar 

  • Nenadic-Sviglin K, Nedic G, Nikolac M, Kozaric-Kovacic D, Stipcevic T, Muck-Seler D, Pivac N (2011) Suicide attempt, comorbid depression and platelet serotonin in alcohol dependence. Alcohol 45:209–216

    Article  PubMed  CAS  Google Scholar 

  • Schmidt AW, Lebel LA, Howard HR Jr, Zorn SH (2001) Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 425:197–201

    Article  PubMed  CAS  Google Scholar 

  • Stahl SM, Shayegan DK (2007) The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice. J Clin Psychiatr 64(Suppl 19):6–12

    Google Scholar 

  • Tatsumi M, Jansen K, Blakely RD, Richelson E (1999) Pharmacological profile of neuroleptics at human monoamine transporters. Eur J Pharmacol 368:277–283

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Thanks are due to the psychiatric staff of the Clinical Hospital Centre Zagreb, Zagreb, Croatia. This work was supported by the Croatian Ministry of Science, Education and Sport (MSES), grants numbers 098-0982522-2455, 098-0922522-2457, 108-1083509-3513 and 108-1080037-0323. The comments in this work are solely the responsibility of the authors and do not necessarily represent the official views of the MSES. All protocols were approved by hospital review board and the Ethics Committee of the University Hospital Centre Zagreb and were therefore in line with the guidelines of the Declaration of Helsinki. There is no conflict of interest in relation to this article.

Author information

Authors and Affiliations

  1. Department of Psychiatry, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Kispaticeva 12, HR-10000, Zagreb, Croatia

    Marina Sagud, Alma Mihaljevic-Peles, Bjanka Vuksan Cusa & Miro Jakovljevic

  2. Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka 54, HR-10000, Zagreb, Croatia

    Matea Nikolac, Gordana Nedic, Maja Mustapic, Dorotea Muck-Seler & Nela Pivac

Authors
  1. Marina Sagud
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matea Nikolac
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alma Mihaljevic-Peles
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gordana Nedic
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bjanka Vuksan Cusa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maja Mustapic
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Miro Jakovljevic
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dorotea Muck-Seler
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nela Pivac
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nela Pivac.

Additional information

Authorship

All authors have made a significant contribution to the conception and design or the analysis and interpretation of data, have participated in drafting the article or reviewing and/or revising it for intellectual content, and have approved the final version of the manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sagud, M., Nikolac, M., Mihaljevic-Peles, A. et al. The lack of effect of ziprasidone on platelet serotonin concentration in schizophrenic patients. Psychopharmacology 219, 1179–1181 (2012). https://doi.org/10.1007/s00213-011-2528-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-011-2528-5

Keywords

Search

Navigation